Terms: = Uterine cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
9431 results:
1. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
Liu Y; Shi W; Mubarik S; Wang F
BMC Public Health; 2024 May; 24(1):1349. PubMed ID: 38764017
[TBL] [Abstract] [Full Text] [Related]
2. Achieving NPVR ≥ 80% as technical success of high-intensity focused ultrasound ablation for uterine fibroids: a cohort study.
Li S; Yang M; Yu J; Ma W; Deng Y; Hu L; Chen JY
BMC Womens Health; 2024 May; 24(1):294. PubMed ID: 38762488
[TBL] [Abstract] [Full Text] [Related]
3. Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
Dong B; Zhou SF
BMC Womens Health; 2024 May; 24(1):297. PubMed ID: 38762459
[TBL] [Abstract] [Full Text] [Related]
4. Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.
Halle MK; Hodneland E; Wagner-Larsen KS; Lura NG; Fasmer KE; Berg HF; Stokowy T; Srivastava A; Forsse D; Hoivik EA; Woie K; Bertelsen BI; Krakstad C; Haldorsen IS
Sci Rep; 2024 May; 14(1):11339. PubMed ID: 38760387
[TBL] [Abstract] [Full Text] [Related]
5. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
Hou PX; Fan Q; Zhang Q; Liu JJ; Wu Q
Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13868. PubMed ID: 38745265
[TBL] [Abstract] [Full Text] [Related]
6. Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
Lei L; Zhang L; Zheng Y; Ma W; Liu F; Li D; Chen K; Zeng Y
BMC Cancer; 2024 May; 24(1):575. PubMed ID: 38724921
[TBL] [Abstract] [Full Text] [Related]
7. Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
Zeng F; Guo P; Xia M; He M
J Cancer Res Clin Oncol; 2024 May; 150(5):236. PubMed ID: 38710946
[TBL] [Abstract] [Full Text] [Related]
8. Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
Newton C; Graham R; Liberale V; Burnell M; Menon U; Mould T; Olaitan A; Macdonald N; Widschwendter M; Doufekas K; McCormack M; Mitra A; Arora R; Manchanda R
J Obstet Gynaecol; 2024 Dec; 44(1):2344529. PubMed ID: 38708782
[TBL] [Abstract] [Full Text] [Related]
9. Histological assessment of endometrial polyps resected by hysteroscopy.
Tekin S; Ocal A; Sisman E; Bilginer C; Cetin A
Eur Rev Med Pharmacol Sci; 2024 Apr; 28(8):3241-3250. PubMed ID: 38708482
[TBL] [Abstract] [Full Text] [Related]
10. Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: A cross-sectional study.
Mooses K; Šavrova A; Pajusalu M; Oja M; Tamm S; Haug M; Padrik L; Laanpere M; Uusküla A; Kolde R
Prev Med; 2024 Jun; 183():107982. PubMed ID: 38701952
[TBL] [Abstract] [Full Text] [Related]
11. Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer - the SENTRY clinical trial.
Sorokin P; Novozhilov M; Utkin D; Abduragimova Z; Dudina I; Nikiforchin A; Kulikova S
Klin Onkol; 2024; 38(2):126-133. PubMed ID: 38697821
[TBL] [Abstract] [Full Text] [Related]
12. Metformin for endometrial hyperplasia.
Shiwani H; Clement NS; Daniels JP; Atiomo W
Cochrane Database Syst Rev; 2024 May; 5(5):CD012214. PubMed ID: 38695827
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
Zhou Y; Wang W; Tang J; Hu K; Zhang F
BMC Cancer; 2024 Apr; 24(1):548. PubMed ID: 38689248
[TBL] [Abstract] [Full Text] [Related]
14. A Comparative Study of Clinical Outcomes in Locally Advanced Cervical cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A Tertiary Care Center Randomized Controlled Trial in India.
Alim S; Siddiqui SA; Akram M; Hakim S; Khan MA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1333-1338. PubMed ID: 38679994
[TBL] [Abstract] [Full Text] [Related]
15. Epidemiology of uterine cancer in Sarawak, Borneo, A 20-Year Review.
Jawa D; Wong KY; Wahab MB; Azhar A; Foong EJ; Joseph EM; Pangkas J; Ooi CH
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1143-1153. PubMed ID: 38679973
[TBL] [Abstract] [Full Text] [Related]
16. Senescence-associated secretory phenotype (SASP) and uterine fibroids: Association with PD-L1 activation and collagen deposition.
Saad EE; Michel R; Borahay MA
Ageing Res Rev; 2024 Jun; 97():102314. PubMed ID: 38670462
[TBL] [Abstract] [Full Text] [Related]
17. Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical cancer Cells.
Mehta H; Ambele MA; Mokgautsi N; Moela P
Cells; 2024 Apr; 13(8):. PubMed ID: 38667315
[TBL] [Abstract] [Full Text] [Related]
18. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
19. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
[No Abstract] [Full Text] [Related]
20. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract] [Full Text] [Related]
[Next]